{"id":3455,"date":"2025-07-09T14:55:24","date_gmt":"2025-07-09T20:55:24","guid":{"rendered":"https:\/\/ahflatamycaribe.org\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/"},"modified":"2025-07-09T16:13:57","modified_gmt":"2025-07-09T22:13:57","slug":"gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih","status":"publish","type":"post","link":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/","title":{"rendered":"Gilead\u2019s Greed Costs Latin America HIV Protection"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><b>MEXICO CITY<\/b><span style=\"font-weight: 400;\"> \u2013 AIDS Healthcare Foundation (AHF) denounces Gilead Sciences for once again excluding Latin America and the Caribbean (LAC) from affordable access to a groundbreaking HIV prevention drug, lenacapavir. Today\u2019s announcement of a pricing and procurement deal between Gilead and the Global Fund to Fight AIDS, Tuberculosis and Malaria leaves most countries in the region out, forcing them to negotiate individually and in secrecy.<\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">\u201cOnce again, Latin America and the Caribbean have been pushed to the margins of progress,\u201d said Dr. Patricia Campos, AHF Bureau Chief for Latin America and the Caribbean. \u201cWhile we applaud efforts to expand access elsewhere, our region is left to fend for itself\u2014facing rising HIV rates, shrinking foreign aid, and now the added burden of opaque pricing negotiations with a pharmaceutical giant that prioritizes patents over people.\u201d<\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">The Global Fund\u2019s deal with Gilead represents a potential step forward for some low- and middle-income countries. AHF acknowledges and deeply values the Global Fund\u2019s life-saving work, especially during this period of economic uncertainty and reductions in foreign aid. However, the terms of this new agreement underscore the persistent inequalities in access to medical innovation\u2014inequalities driven not by science but by corporate profit motives.<\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">According to Gilead\u2019s own announcement, many Latin American countries with high HIV burdens \u201care not covered by this agreement.\u201d These countries were also excluded from the company\u2019s earlier licensing arrangement for generic production of lenacapavir, leaving them at the mercy of <\/span><b>Greedy Gilead\u2019s<\/b><span style=\"font-weight: 400;\"> closed-door pricing policies and monopolistic control.<\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">AHF strongly opposes secret pricing agreements and reiterates its call for transparency, equity, and public accountability in global access to HIV prevention.<\/span><br\/><br\/><span style=\"font-weight: 400;\">In solidarity with Public Citizen and more than 100 civil society organizations across the region, AHF urges governments in Latin America and the Caribbean to:<\/span><\/p>\n\n<ul class=\"wp-block-list\">\n<li>Strengthen legal frameworks to enable compulsory licensing of essential medicines;<br\/><\/li>\n\n\n\n<li>Challenge evergreening patents through patent oppositions;<\/li>\n\n\n\n<li>Declare long-acting PrEP drugs like lenacapavir as medicines of public interest, unlocking pathways for affordable generic competition.<br\/><\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Countries like Colombia, which recently issued a compulsory license for the HIV medication dolutegravir, are setting an important precedent. Other governments in the region must urgently follow suit to overcome pharmaceutical barriers and scale up prevention.<\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">\u201cThe science is ready. The tools are available. What\u2019s missing is equitable access\u2014and that is something governments can and must act on now,\u201d said Guillermina Alaniz, AHF Director of Global Advocacy &amp; Policy, based in Argentina. \u201cTogether with Public Citizen and a growing coalition of civil society allies, we are building momentum across Latin America to challenge unjust monopolies and ensure lifesaving HIV prevention reaches everyone\u2014no matter where they live.\u201d<\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.<\/p>\n","protected":false},"author":15,"featured_media":3449,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-3455","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Tina Guti\u00e9rrez\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"AHF Latam &amp; Caribe - Medicina de vanguardia y abogac\u00eda sin importar la capacidad de pago\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Gilead\u2019s Greed Costs Latin America HIV Protection - AHF Latam &amp; Caribe\" \/>\n\t\t<meta property=\"og:description\" content=\"AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-07-09T20:55:24+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-07-09T22:13:57+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AHFLatamyCaribe\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@AHFLatamyCaribe\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Gilead\u2019s Greed Costs Latin America HIV Protection - AHF Latam &amp; Caribe\" \/>\n\t\t<meta name=\"twitter:description\" content=\"AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@AHFLatamyCaribe\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#blogposting\",\"name\":\"Gilead\\u2019s Greed Costs Latin America HIV Protection - AHF Latam & Caribe\",\"headline\":\"Gilead\\u2019s Greed Costs Latin America HIV Protection\",\"author\":{\"@id\":\"#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ahflatamycaribe.org\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Articulo-Lenacapavir-9-julio.jpg\",\"width\":1080,\"height\":600},\"datePublished\":\"2025-07-09T14:55:24-06:00\",\"dateModified\":\"2025-07-09T16:13:57-06:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#webpage\"},\"articleSection\":\"News, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/category\\\/news-en\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/category\\\/news-en\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/category\\\/news-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#listItem\",\"name\":\"Gilead\\u2019s Greed Costs Latin America HIV Protection\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#listItem\",\"position\":3,\"name\":\"Gilead\\u2019s Greed Costs Latin America HIV Protection\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/category\\\/news-en\\\/#listItem\",\"name\":\"News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/#organization\",\"name\":\"AHF Latam & Caribe\",\"description\":\"Medicina de vanguardia y abogac\\u00eda sin importar la capacidad de pago\",\"url\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ahflatamycaribe.org\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Logo_Latam.svg\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#organizationLogo\",\"width\":500,\"height\":225},\"image\":{\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AHFLatamyCaribe\\\/\",\"https:\\\/\\\/twitter.com\\\/AHFLatamyCaribe?ref_src=twsrcgoogletwcampserptwgrauthor\",\"https:\\\/\\\/www.youtube.com\\\/@ahflatamcaribbean3741\"]},{\"@type\":\"Person\",\"@id\":\"#author\",\"name\":\"Tina Guti\\u00e9rrez\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#webpage\",\"url\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/\",\"name\":\"Gilead\\u2019s Greed Costs Latin America HIV Protection - AHF Latam & Caribe\",\"description\":\"AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ahflatamycaribe.org\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Articulo-Lenacapavir-9-julio.jpg\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#mainImage\",\"width\":1080,\"height\":600},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\\\/#mainImage\"},\"datePublished\":\"2025-07-09T14:55:24-06:00\",\"dateModified\":\"2025-07-09T16:13:57-06:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/\",\"name\":\"AHF Latam & Caribe\",\"description\":\"Medicina de vanguardia y abogac\\u00eda sin importar la capacidad de pago\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/ahflatamycaribe.org\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Gilead\u2019s Greed Costs Latin America HIV Protection - AHF Latam &amp; Caribe<\/title>\n\n","aioseo_head_json":{"title":"Gilead\u2019s Greed Costs Latin America HIV Protection - AHF Latam & Caribe","description":"AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.","canonical_url":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#blogposting","name":"Gilead\u2019s Greed Costs Latin America HIV Protection - AHF Latam & Caribe","headline":"Gilead\u2019s Greed Costs Latin America HIV Protection","author":{"@id":"#author"},"publisher":{"@id":"https:\/\/ahflatamycaribe.org\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg","width":1080,"height":600},"datePublished":"2025-07-09T14:55:24-06:00","dateModified":"2025-07-09T16:13:57-06:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#webpage"},"isPartOf":{"@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#webpage"},"articleSection":"News, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/ahflatamycaribe.org\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/ahflatamycaribe.org\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/ahflatamycaribe.org\/en\/category\/news-en\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/ahflatamycaribe.org\/en\/category\/news-en\/#listItem","position":2,"name":"News","item":"https:\/\/ahflatamycaribe.org\/en\/category\/news-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#listItem","name":"Gilead\u2019s Greed Costs Latin America HIV Protection"},"previousItem":{"@type":"ListItem","@id":"https:\/\/ahflatamycaribe.org\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#listItem","position":3,"name":"Gilead\u2019s Greed Costs Latin America HIV Protection","previousItem":{"@type":"ListItem","@id":"https:\/\/ahflatamycaribe.org\/en\/category\/news-en\/#listItem","name":"News"}}]},{"@type":"Organization","@id":"https:\/\/ahflatamycaribe.org\/en\/#organization","name":"AHF Latam & Caribe","description":"Medicina de vanguardia y abogac\u00eda sin importar la capacidad de pago","url":"https:\/\/ahflatamycaribe.org\/en\/","logo":{"@type":"ImageObject","url":"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2023\/08\/Logo_Latam.svg","@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#organizationLogo","width":500,"height":225},"image":{"@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/AHFLatamyCaribe\/","https:\/\/twitter.com\/AHFLatamyCaribe?ref_src=twsrcgoogletwcampserptwgrauthor","https:\/\/www.youtube.com\/@ahflatamcaribbean3741"]},{"@type":"Person","@id":"#author","name":"Tina Guti\u00e9rrez"},{"@type":"WebPage","@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#webpage","url":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/","name":"Gilead\u2019s Greed Costs Latin America HIV Protection - AHF Latam & Caribe","description":"AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/ahflatamycaribe.org\/en\/#website"},"breadcrumb":{"@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg","@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#mainImage","width":1080,"height":600},"primaryImageOfPage":{"@id":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/#mainImage"},"datePublished":"2025-07-09T14:55:24-06:00","dateModified":"2025-07-09T16:13:57-06:00"},{"@type":"WebSite","@id":"https:\/\/ahflatamycaribe.org\/en\/#website","url":"https:\/\/ahflatamycaribe.org\/en\/","name":"AHF Latam & Caribe","description":"Medicina de vanguardia y abogac\u00eda sin importar la capacidad de pago","inLanguage":"en-US","publisher":{"@id":"https:\/\/ahflatamycaribe.org\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"AHF Latam &amp; Caribe - Medicina de vanguardia y abogac\u00eda sin importar la capacidad de pago","og:type":"article","og:title":"Gilead\u2019s Greed Costs Latin America HIV Protection - AHF Latam &amp; Caribe","og:description":"AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.","og:url":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/","og:image":"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg","og:image:secure_url":"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg","og:image:width":"1080","og:image:height":"600","article:published_time":"2025-07-09T20:55:24+00:00","article:modified_time":"2025-07-09T22:13:57+00:00","article:publisher":"https:\/\/www.facebook.com\/AHFLatamyCaribe\/","twitter:card":"summary_large_image","twitter:site":"@AHFLatamyCaribe","twitter:title":"Gilead\u2019s Greed Costs Latin America HIV Protection - AHF Latam &amp; Caribe","twitter:description":"AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.","twitter:creator":"@AHFLatamyCaribe","twitter:image":"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg"},"aioseo_meta_data":{"post_id":"3455","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"featured","og_image_url":"https:\/\/ahflatamycaribe.org\/wp-content\/uploads\/2025\/07\/Articulo-Lenacapavir-9-julio.jpg","og_image_width":"1080","og_image_height":"600","og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":"2026-05-13 05:08:15","limit_modified_date":false,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2025-07-09 21:25:41","updated":"2026-05-13 05:08:15","breadcrumb_settings":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/ahflatamycaribe.org\/en\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/ahflatamycaribe.org\/en\/category\/news-en\/\" title=\"News\">News<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tGilead\u2019s Greed Costs Latin America HIV Protection\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/ahflatamycaribe.org\/en\/"},{"label":"News","link":"https:\/\/ahflatamycaribe.org\/en\/category\/news-en\/"},{"label":"Gilead\u2019s Greed Costs Latin America HIV Protection","link":"https:\/\/ahflatamycaribe.org\/en\/gilead-excluye-a-al-del-tratamiento-clave-contra-el-vih\/"}],"_links":{"self":[{"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/posts\/3455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/comments?post=3455"}],"version-history":[{"count":0,"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/posts\/3455\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/media\/3449"}],"wp:attachment":[{"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/media?parent=3455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/categories?post=3455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ahflatamycaribe.org\/en\/wp-json\/wp\/v2\/tags?post=3455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}